Shenzhen Salubris Pharmaceuticals Co Ltd (002294) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.045x

Based on the latest financial reports, Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a cash flow conversion efficiency ratio of 0.045x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥400.70 Million ≈ $58.63 Million USD) by net assets (CN¥8.93 Billion ≈ $1.31 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shenzhen Salubris Pharmaceuticals Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Shenzhen Salubris Pharmaceuticals Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Shenzhen Salubris Pharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shenzhen Salubris Pharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen Salubris Pharmaceuticals Co Ltd ranked by their cash flow conversion efficiency. Explore 002294 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Mega Or
TA:MGOR
0.054x
BRD Groupe Societe Generale SA
RO:BRD
0.308x
Scout24 AG
XETRA:G24
0.101x
Shandong Intco Medical Products Co Ltd
SHE:300677
0.024x
FOSITEK CORP
TW:6805
0.047x
Laureate Education Inc
NASDAQ:LAUR
0.089x
Iridium Communications Inc
NASDAQ:IRDM
0.242x
Vipshop Holdings Limited
NYSE:VIPS
N/A

Annual Cash Flow Conversion Efficiency for Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024. View 002294 live share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥8.75 Billion
≈ $1.28 Billion
CN¥1.19 Billion
≈ $173.59 Million
0.136x +25.52%
2023-12-31 CN¥8.06 Billion
≈ $1.18 Billion
CN¥869.79 Million
≈ $127.28 Million
0.108x -11.28%
2022-12-31 CN¥7.98 Billion
≈ $1.17 Billion
CN¥970.80 Million
≈ $142.06 Million
0.122x -17.36%
2021-12-31 CN¥8.05 Billion
≈ $1.18 Billion
CN¥1.18 Billion
≈ $173.40 Million
0.147x -40.08%
2020-12-31 CN¥5.59 Billion
≈ $818.24 Million
CN¥1.37 Billion
≈ $201.11 Million
0.246x +8.75%
2019-12-31 CN¥6.67 Billion
≈ $975.50 Million
CN¥1.51 Billion
≈ $220.47 Million
0.226x +15.83%
2018-12-31 CN¥6.87 Billion
≈ $1.01 Billion
CN¥1.34 Billion
≈ $196.18 Million
0.195x -17.57%
2017-12-31 CN¥6.16 Billion
≈ $901.18 Million
CN¥1.46 Billion
≈ $213.31 Million
0.237x -9.93%
2016-12-31 CN¥5.46 Billion
≈ $798.98 Million
CN¥1.43 Billion
≈ $209.96 Million
0.263x +16.85%
2015-12-31 CN¥4.70 Billion
≈ $687.12 Million
CN¥1.06 Billion
≈ $154.53 Million
0.225x -13.27%
2014-12-31 CN¥3.79 Billion
≈ $554.32 Million
CN¥982.25 Million
≈ $143.73 Million
0.259x +21.59%
2013-12-31 CN¥3.13 Billion
≈ $458.73 Million
CN¥668.52 Million
≈ $97.83 Million
0.213x +6.65%
2012-12-31 CN¥2.61 Billion
≈ $381.44 Million
CN¥521.21 Million
≈ $76.27 Million
0.200x +56.74%
2011-12-31 CN¥2.13 Billion
≈ $312.36 Million
CN¥272.32 Million
≈ $39.85 Million
0.128x +27.50%
2010-12-31 CN¥1.87 Billion
≈ $272.96 Million
CN¥186.65 Million
≈ $27.31 Million
0.100x +20.96%
2009-12-31 CN¥1.62 Billion
≈ $237.55 Million
CN¥134.28 Million
≈ $19.65 Million
0.083x -72.08%
2008-12-31 CN¥262.90 Million
≈ $38.47 Million
CN¥77.89 Million
≈ $11.40 Million
0.296x -18.02%
2007-12-31 CN¥145.96 Million
≈ $21.36 Million
CN¥52.75 Million
≈ $7.72 Million
0.361x +220.57%
2006-12-31 CN¥106.48 Million
≈ $15.58 Million
CN¥12.00 Million
≈ $1.76 Million
0.113x --

About Shenzhen Salubris Pharmaceuticals Co Ltd

SHE:002294 China Drug Manufacturers - Specialty & Generic
Market Cap
$4.96 Billion
CN¥33.89 Billion CNY
Market Cap Rank
#3598 Global
#500 in China
Share Price
CN¥30.40
Change (1 day)
+0.70%
52-Week Range
CN¥29.60 - CN¥68.30
All Time High
CN¥68.30
About

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines and medical devices in China. The company offers drugs for various therapeutic fields, such as thrombosis, hypertension and related diseases, osteoporosis, and infections, as well as anti-osteolysis, antiallergic, antiepileptic, and antidepressant medicines. It also develops Sacubit… Read more